Top compounds associated with response to ZNF195


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.2 2e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.18 3e-06
mRNA CAY10603 GDSC1000 pan-cancer AAC 0.15 3e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA PIK-93 GDSC1000 pan-cancer AAC 0.15 4e-06
mRNA FK866 GDSC1000 pan-cancer AAC 0.15 5e-06
mRNA Panobinostat CTRPv2 pan-cancer AAC 0.16 5e-06
Download CSV